ArticleJournal of proteome research2026
A Degradomic Landscape of Proteolytic Remodeling in Melanoma Lung Metastasis.
Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma metastasis involves extensive remodeling of the tumor microenvironment, yet the proteolytic processes underlying pulmonary colonization remain poorly defined. Using the B16F10 intravenous melanoma model in C57BL/6J mice, we performed an integrative degradomic analysis of metastatic lung tissue, plasma, and secretome of early passaged primary cultures derived from metastatic foci. Semispecific database searches identified nearly 8,000 semitryptic peptides across compartments, with the secretome exhibiting the highest burden of cleavage events, indicating an intensely proteolytic microenvironment. Cleavage profiles were compartment-specific, dominated by actin in metastatic lung tissue, α2-macroglobulin in plasma, and SPARC in the secretome. Cleavage-site motif analysis revealed conserved His/Ser (P1/P1') preferences in tissue and plasma, whereas the secretome showed a distinct Leu/Ser pattern. Discriminant-feature analysis uncovered unique proteolytic signatures for each compartment, and peptide-level mapping implicated at least 11 proteases─including MMP2, cathepsin D, and cathepsin E─as major contributors to metastatic niche remodeling. Functional enrichment demonstrated coordinated impacts on extracellular matrix organization, inflammation, and metabolic adaptation. This work provides a multicompartment degradomic resource that captures proteolytic remodeling in melanoma lung metastasis and establishes a foundation for future functional and translational studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.